Back
Biomea Fusion Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Sell
16
BMEA
Biomea Fusion
Last Price:
7.11
Seasonality Move:
29.9%
Buy
60
CRNX
Crinetics Pharmaceuticals
Last Price:
59.72
Seasonality Move:
9.3%
Sell
16
Biomea Fusion (BMEA)
is a Sell
Is Biomea Fusion a Buy, Sell or Hold?
- The current Biomea Fusion [BMEA] share price is $7.10. The Score for BMEA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- BMEA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Crinetics Pharmaceuticals (CRNX)
is a Buy
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
- The current Crinetics Pharmaceuticals [CRNX] share price is $58.92. The Score for CRNX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- CRNX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMEA Stock Price Chart
What is Biomea Fusion's stock price today?
-
The Biomea Fusion share price today is $7.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMEA is experiencing selling pressure, which indicates risk of future bearish movement.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $58.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.
BMEA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.63 | Sell |
| Relative Strength Index (14 RSI): | 26.4 | Sell |
| Chaikin Money Flow: | -995934 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.64 - 11.68) | Sell |
| Bollinger Bands (100): | (5.28 - 9.84) | Sell |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.35 | Buy |
| Relative Strength Index (14 RSI): | 58.51 | Buy |
| Chaikin Money Flow: | -780726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.69 - 59.83) | Buy |
| Bollinger Bands (100): | (48.73 - 56.63) | Buy |
BMEA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.27 | Sell |
| 20-day SMA: | 10.01 | Sell |
| 50-day SMA: | 9.45 | Sell |
| 200-day SMA: | 10.42 | Sell |
| 8-day EMA: | 8.31 | Sell |
| 20-day EMA: | 9.26 | Sell |
| 50-day EMA: | 9.21 | Sell |
| 200-day EMA: | 10.13 | Sell |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.99 | Sell |
| 20-day SMA: | 58.26 | Buy |
| 50-day SMA: | 54.58 | Buy |
| 200-day SMA: | 48.24 | Buy |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 57.69 | Buy |
| 50-day EMA: | 55.44 | Buy |
| 200-day EMA: | 47.9 | Buy |
Biomea Fusion Earnings Growth & BMEA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.54 per share, and an increase next year of $0.80 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.21 per share.
Biomea Fusion Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||